Abstract
The proteolytic enzyme renin seems to play an important part in the humoral control of blood pressure by initiating a reaction which finally leads to the production of the vasoconstrictor peptide angiotensin II. However, it has recently been shown that normal human plasma contains a higher molecular weight form of renin (prorenin), which is enzymatically inactive1–6. In vitro, prorenin is converted to the active renin enzyme by various unphysiological procedures such as cryoactivation7–9, acid activation1,6,7,9 or the addition of trypsin10,11 or pepsin11,12, the activation by trypsin being equal to that by acidification13–15. Although the physiological role of prorenin remains unclear, it has been shown that differences exist in the response to stimuli between prorenin and the active renin enzyme3,6,7. Recently, it has been shown that serine protease(s) may be involved in the activation process of prorenin, during both cryoactivation7,16 and acid activation7. Furthermore, human urinary kallikrein added to plasma in low concentrations is able to activate prorenin completely in vitro17. Therefore, it has been speculated that urinary kallikrein might be the physiological in vivo activator of prorenin17–19. This also seemed plausible because renal kallikrein is produced in cells adjacent to the renin-producing cells20. On the other hand, plasma kallikrein has been implicated in the activation of prorenin 15,21–23. In the experiments described below we tried to obtain some more direct evidence for the in vivo role of kallikrein(s) in the prorenin activation. Our results suggest that plasma kallikrein may indeed be a physiological activator of prorenin, but they do not support a role for urinary (renal) kallikrein in the activation of prorenin.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Day, R. P., Luetscher, J. A. & Gonzales, C. M. J. clin. Endocr. Metab. 40, 1078–1084 (1975).
Skinner, S. L. et al. Am. J. Obstet. Gynecol. 121, 626–630 (1975).
Derkx, F. H. M. et al. Lancet ii, 496–498 (1976).
Leckie, B. J. et al. Circulation Res. 40, Suppl. 1, 46–51 (1977).
Boyd, G. W. Lancet i, 215–218 (1977).
Rumpf, K. W., Schächterle, B., Schmidt, S., Becker, K. & Scheler, F. Clin. Sci. molec. Med. 55, 155s–157s (1978).
Atlas, S. A., Sealey, J. E. & Laragh, J. H. Circulation Res. 43, Suppl. 1, 128–133 (1978).
Sealey, J. E., Moon, C., Laragh, J. H. & Alderman, M. Am. J. Med. 61, 731–738 (1976).
Hummerich, W., Konrads, A., Schrappe, M., Helber, A. & Wambrach, G. Klin. Wschr. 57, 475–477 (1979).
Cooper, R. M., Murray, G. E. & Osmond, D. H. Circulation Res. 40, Suppl. 1, 171–179 (1977).
Morris, B. J. & Lumbers, E. R. Biochim. biophys. Acta 289, 385–391 (1972).
Shulkes, A. A., Gibson, R. R. & Skinner, S. L. Clin. Sci. molec. Med. 55, 41–50 (1978).
Leckie, B. J., McConnell, A. & Jordan, J. Adv. exp. Med. Biol. 95, 249–269 (1977).
Hara, A. et al. Clin. Sci. molec. Med. 55, 139s–141s (1978).
Derkx, F. H. M., Douma, B. N., Schalekamp, M. P. A. & Schalekamp, M. A. D. H. Nature 280, 315–316 (1979).
Osmond, D. H. & Loh, A. Y. Lancet i, 102 (1978).
Sealey, J. E., Atlas, S. A., Laragh, J. H., Oza, N. B. & Ryan, J. W. Nature 275, 144–145 (1978).
Sealey, J. E., Atlas, S. A. & Laragh, J. H. Am. J. Med. 65, 994–1000 (1978).
Sealey, J. E., Atlas, S. A., Laragh, J. H., Oza, N. B. & Ryan, J. W. Hypertension 1, 179–189 (1979).
Scicli, A. G., Carretero, O. A., Oza, N. B. & Schork, N. A. Proc. Soc. exp. Biol. Med. 151, 57–60 (1976).
Sealey, J. E., Atlas, S. A., Laragh, J. H., Silverberg, M. & Kaplan, A. P. Clin. Res. 27, 479A (1979).
Sealey, J. E., Silverberg, M., Laragh, J. H., Atlas, S. A. & Kaplan, A. P. Fedn Proc. 38, 677 (1979).
Tatemichi, S. R. & Osmond, D. H. Lancet i, 1313 (1978).
Claeson, G., Friberger, P., Knös, M. & Eriksson, E. Haemostasis 7, 76–78 (1978).
Stormorken, H., Baklund, A., Gallimore, M. & Ritland, R. Haemostasis 7, 69–75 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rumpf, K., Becker, K., Kreusch, U. et al. Evidence for a role of plasma kallikrein in the activation of prorenin. Nature 283, 482–483 (1980). https://doi.org/10.1038/283482a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/283482a0
This article is cited by
-
Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system
BMC Medical Genetics (2016)
-
Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency
Research in Experimental Medicine (1985)
-
Reversible activation–inactivation of renin in human plasma
Nature (1980)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.